#1 Clinical Trials Search in Europe

Tetracosactide

Tetracosactide, also known as Synacthen or cosyntropin, is a synthetic analogue of adrenocorticotropic hormone (ACTH) used in various clinical trials to assess adrenal function and explore potential therapeutic applications. This article delves into the diverse uses of Tetracosactide in clinical research, ranging from diagnosing adrenal insufficiency to investigating its effects on conditions such as membranous nephropathy and polycystic ovary syndrome.

Table of Contents

What is Tetracosactide?

Tetracosactide, also known by its brand names Synacthen or Cosyntropin, is a synthetic form of a hormone called adrenocorticotropic hormone (ACTH)[1]. ACTH is naturally produced by the pituitary gland in your brain and plays a crucial role in stimulating the adrenal glands to produce cortisol, a vital hormone for many bodily functions[2].

Medical Uses

Tetracosactide is used for both diagnostic and therapeutic purposes:

  • Diagnosing Adrenal Insufficiency: It’s commonly used in a test called the Short Synacthen Test (SST) to check if your adrenal glands are producing enough cortisol[2].
  • Treating Adrenal Insufficiency: In some cases, it may be used to treat conditions where the body doesn’t produce enough cortisol[3].
  • Managing Autoimmune Conditions: It’s being studied for treating certain kidney diseases like membranous nephropathy[4].
  • Relieving Post-Dural Puncture Headaches: Research is ongoing to determine if it can help with headaches that sometimes occur after certain medical procedures[5].

How It Works

When tetracosactide is administered, it mimics the action of natural ACTH in your body. It travels through your bloodstream to the adrenal glands, which sit on top of your kidneys. There, it stimulates the adrenal glands to produce and release cortisol and other steroid hormones[1].

Cortisol is often called the “stress hormone” because it helps your body respond to stress. It also plays important roles in regulating blood sugar, reducing inflammation, and controlling blood pressure[2].

Administration

Tetracosactide can be given in several ways:

  • Intravenous (IV) Injection: Directly into a vein, often used for diagnostic tests[1].
  • Intramuscular (IM) Injection: Into a muscle, sometimes used for longer-term treatment[4].
  • Nasal Administration: Research is being conducted on a nasal spray form, which could be less invasive and more convenient, especially for children[2].

The dose and frequency of administration depend on the specific medical condition and whether it’s being used for diagnosis or treatment[3].

Side Effects

While tetracosactide is generally considered safe when used as directed, it can cause some side effects. These may include:

  • Dizziness
  • Headache
  • Nausea
  • Flushing (redness of the skin)
  • Changes in mood or behavior

In rare cases, more serious side effects can occur. Always inform your healthcare provider about any unusual symptoms you experience[5].

Ongoing Research

Scientists are continually studying tetracosactide to understand its full potential. Some areas of current research include:

  • Adrenal Gland Regeneration: Researchers are investigating whether long-term use of tetracosactide could help regenerate adrenal gland function in people with autoimmune Addison’s disease[3].
  • Hormone Disorders in Children: Studies are looking at how tetracosactide affects hormone levels in girls with conditions like polycystic ovary syndrome (PCOS)[6].
  • Liver Disease: Research is exploring the relationship between adrenal function and liver cirrhosis, using tetracosactide to assess adrenal function[7].
  • Heart Surgery in Infants: Scientists are studying how tetracosactide affects stress responses in infants undergoing heart surgery[8].

These ongoing studies aim to expand our understanding of tetracosactide and potentially uncover new uses for this medication.

Aspect Details
Primary Uses in Clinical Trials – Assessing adrenal function (Short Synacthen Test)
– Investigating potential therapeutic applications
Conditions Studied – Adrenal insufficiency
– Membranous nephropathy
– Polycystic ovary syndrome
– Autoimmune Addison’s disease
– Adrenal suppression in asthma patients
Administration Methods – Intravenous injection
– Intramuscular injection
– Nasal administration (in development)
Patient Groups – Adults
– Children
– Obese individuals
– Patients with cirrhosis
Key Measurements – Cortisol levels
– Other adrenal hormones
– Bioavailability
– Pharmacokinetics
Emerging Research – Non-invasive testing methods
– Adrenal function regeneration
– Long-term effects on various conditions

FAQ

  • What is Tetracosactide and how is it used in clinical trials? Tetracosactide is a synthetic version of ACTH used to stimulate the adrenal glands. In clinical trials, it's primarily used to assess adrenal function through tests like the Short Synacthen Test (SST). It's also being studied for potential therapeutic applications in various conditions.
  • What is the Short Synacthen Test (SST)? The Short Synacthen Test is a diagnostic procedure that uses Tetracosactide to evaluate the adrenal glands' ability to produce cortisol. It typically involves injecting Tetracosactide and measuring cortisol levels in blood or saliva samples taken before and after the injection.
  • Are there any non-invasive alternatives to the traditional SST being developed? Yes, researchers are working on developing a non-invasive Short Synacthen Test. This involves administering Synacthen nasally and using saliva samples to measure cortisol production, making the test more comfortable for patients, especially children.
  • In which medical conditions is Tetracosactide being studied? Tetracosactide is being studied in various conditions, including adrenal insufficiency, membranous nephropathy, polycystic ovary syndrome, and autoimmune Addison's disease. It's also being investigated for its potential in regenerating adrenal function in some patients.
  • Are there any special considerations for using Tetracosactide in children or specific patient groups? Yes, researchers are studying the use of Tetracosactide in children, particularly for diagnosing adrenal suppression in those using inhaled steroids for asthma. There are also studies focusing on its use in obese girls with androgen excess and in patients with cirrhosis to assess adrenal function.

Ongoing Clinical Trials on Tetracosactide

  • Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    2 1 1 1
    Investigated drugs:
    Austria Germany

  • Study on Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Patients

    Not yet recruiting

    4 1 1
    Investigated drugs:
    Belgium

  • Study on the Long-Term Safety and Effectiveness of Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Germany Italy The Netherlands Poland +2

  • Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

    Not recruiting

    3 1 1
    Investigated drugs:
    Bulgaria France Germany Italy The Netherlands Poland +2

  • Study on the Effects of Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Adults

    Not recruiting

    4 1 1
    Investigated drugs:
    Belgium Czechia Poland

Glossary

  • Adrenal insufficiency: A condition where the adrenal glands don't produce enough of certain hormones, particularly cortisol. It can be diagnosed using tests like the Short Synacthen Test.
  • Cortisol: A hormone produced by the adrenal glands that helps the body respond to stress, regulate blood sugar, and perform other important functions.
  • Short Synacthen Test (SST): A diagnostic test that uses Tetracosactide to assess the adrenal glands' ability to produce cortisol in response to stimulation.
  • Adrenocorticotropic hormone (ACTH): A hormone produced by the pituitary gland that stimulates the adrenal glands to produce cortisol and other hormones.
  • Membranous nephropathy: A kidney disorder that causes problems with the filtering of waste products in the blood, potentially leading to kidney failure.
  • Polycystic ovary syndrome (PCOS): A hormonal disorder in women that can cause irregular periods, excess hair growth, and fertility problems.
  • Autoimmune Addison's disease: A condition where the immune system attacks and damages the adrenal glands, leading to adrenal insufficiency.
  • Bioavailability: The proportion of a drug or substance that enters the circulation when introduced into the body and is able to have an active effect.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.

References

  1. https://clinicaltrials.gov/study/NCT00851942
  2. https://clinicaltrials.gov/study/NCT03514589
  3. https://clinicaltrials.gov/study/NCT01371526
  4. https://clinicaltrials.gov/study/NCT00694863
  5. https://clinicaltrials.gov/study/NCT02813655
  6. https://clinicaltrials.gov/study/NCT01421797
  7. https://clinicaltrials.gov/study/NCT04642391
  8. https://clinicaltrials.gov/study/NCT01839812